From

Institution

Field

Type

Open access only Cited by patents (Lens) Include non-Aachen papers (citing/cited)

Reset

Papers matching “ALK rearrangement” 14

Sort: Relevance Cited Newest Oldest Fwci Patents ⇩ CSV

Not finding it? Sign in to also search OpenAlex live.

ALK-positive histiocytosis: a new clinicopathologic spectrum highlighting neurologic involvement and responses to ALK inhibition
2021 Blood article Medicine Histiocytic Disorders and Treatments Open access

Paul Geraeds Kemps, Jennifer Lee Picarsic, Benjamin Heath Durham, Zofia Hélias‐Rodzewicz, Laura S. Hiemcke‐Jiwa, Cor van den Bos, +72 more

163

citations
Attenuated isolated 3’ signal: A highly challenging therapy relevant ALK FISH pattern in NSCLC
2020 Lung Cancer article Medicine Lung Cancer Treatments and Mutations Open access

Gábor Smuk, Gábor Pajor, Károly Szuhai, Hans M. Morreau, Ildikó Kocsmár, Éva Kocsmár, +5 more

14

citations
Abstract 3191: Detection of molecular drivers in inflammatory myofibroblastic tumor: study on archival tissue from EORTC 90101 “CREATE” phase II clinical trial
2020 Cancer Research conference-abstract Medicine IgG4-Related and Inflammatory Diseases

Agnieszka Woźniak, Che‐Jui Lee, Tom van Wezel, Jozef Šufliarský, Hans A. J. Gelderblom, Jean‐Yves Blay, +4 more

3

citations
RET Fluorescence In Situ Hybridization Analysis Is a Sensitive but Highly Unspecific Screening Method for RET Fusions in Lung Cancer
2021 Journal of Thoracic Oncology article Medicine Lung Cancer Treatments and Mutations Open access

Teodora Radonic, Willemina R.R. Geurts-Giele, Kris G. Samsom, Guido M.J.M. Roemen, Jan H. von der Thüsen, Erik Thunnissen, +13 more

42

citations
Abstract 794: Molecular analysis of archival inflammatory myofibroblastic tumor tissue samples from EORTC 90101 “CREATE” and correlation with response to crizotinib
2020 Cancer Research conference-abstract Medicine IgG4-Related and Inflammatory Diseases Open access

Che‐Jui Lee, Patrick Schöffski, Elodie Modave, Bram Boeckx, Diether Lambrechts, Maria Dêbiec‐Rychter, +5 more

0

citations
Long-term efficacy update of crizotinib in patients with advanced, inoperable inflammatory myofibroblastic tumour from EORTC trial 90101 CREATE
2021 European Journal of Cancer article Medicine IgG4-Related and Inflammatory Diseases Open access

Patrick Schöffski, Michaela Kubičková, Agnieszka Woźniak, Jean‐Yves Blay, Sandra J. Strauss, Silvia Stacchiotti, +12 more

69

citations
TERT promoter mutation analysis as a surrogate to morphology and immunohistochemistry in problematic spindle cell lesions of the urinary bladder
2020 Histopathology article Medicine Urinary and Genital Oncology Studies Open access

Simone Bertz, Robert Stöhr, Nadine Therese Gaisa, Bernd Wullich, Arndt Hartmann, Abbas Agaimy

19

citations
Clinical, Histologic, and Molecular Characteristics of Anaplastic Lymphoma Kinase-positive Primary Cutaneous Anaplastic Large Cell Lymphoma
2020 The American Journal of Surgical Pathology article Medicine Cutaneous lymphoproliferative disorders research Open access cited by 1 patent

Rutger C. Melchers, Rein Willemze, Merel van de Loo, Remco van Doorn, Patty M. Jansen, Arjen H.G. Cleven, +6 more

29

citations
Capmatinib in MET exon 14-mutated non-small-cell lung cancer: final results from the open-label, phase 2 GEOMETRY mono-1 trial
2024 The Lancet Oncology article Medicine Lung Cancer Treatments and Mutations Open access

Jürgen Wolf, Maximilian Johannes Hochmair, Ji‐Youn Han, Noemı́ Reguart, Pierre-Jean Souquet, Egbert Frederik Smit, +20 more

82

citations
Comparative Performance Analysis of Idylla and Archer in the Detection of Gene Fusions in Spitzoid Melanocytic Tumors
2024 Modern Pathology article Medicine Cutaneous Melanoma Detection and Management Open access

Chiel F Ebbelaar, Marijke R. van Dijk, Gerben Eise Breimer, Ruud W. J. Meijers, Laura B. C. Klein, Maryleen M Petronilia, +3 more

3

citations
Profiling patients with MET exon 14 ( MET ex14) skipping NSCLC with a sustained clinical benefit to tepotinib in VISION.
2026 Journal of Clinical Oncology conference-abstract Medicine Lung Cancer Treatments and Mutations

Paul K. Paik, Egbert Frederik Smit, Hélène Senellart, Rémi Veillon, Juergen Alt, Ingel Demedts, +8 more

0

citations
Comprehensive Molecular Analysis of Inflammatory Myofibroblastic Tumors Reveals Diverse Genomic Landscape and Potential Predictive Markers for Response to Crizotinib
2021 Clinical Cancer Research article Medicine IgG4-Related and Inflammatory Diseases Open access

Jean‐Yves Blay

21

citations
Data from Comprehensive Molecular Analysis of Inflammatory Myofibroblastic Tumors Reveals Diverse Genomic Landscape and Potential Predictive Markers for Response to Crizotinib
2023 other Medicine IgG4-Related and Inflammatory Diseases Open access

Che‐Jui Lee, Patrick Schöffski, Elodie Modave, Tom van Wezel, Bram Boeckx, Jozef Šufliarský, +7 more

0

citations
Data from Comprehensive Molecular Analysis of Inflammatory Myofibroblastic Tumors Reveals Diverse Genomic Landscape and Potential Predictive Markers for Response to Crizotinib
2023 other Medicine IgG4-Related and Inflammatory Diseases Open access

Che‐Jui Lee, Patrick Schöffski, Elodie Modave, Tom van Wezel, Bram Boeckx, Jozef Šufliarský, +7 more

0

citations

14 results